Access China offers a variety of different types of research, including the Chinese industry report and market analysis, the Chinese research report of strategic investment, and the consulting services across a variety of Chinese industry sectors, Chinese laws and administrative regulations, licensing, certification concerning trade and strategic investment into China, with a significant capacity for customized work as well as standardized output.
Industry and Trend Analysis
Access China provides a range of industry analysis solutions, which incorporate past and current statistics and trends. After a thorough scrutiny of available information based on historical data and current market conditions, reports are formulated on different industry sectors, such as Pharmaceuticals, Healthcare, Manufacturing and Consumer Goods. Access China’s industry and trend analysis provides you in-depth analysis of the Chinese industry.
Access China’s market analysis synthesizes comprehensive information on market conditions, including acquisition target and expansion strategy on the basis of individual products and strengths for each targeted region, which help you penetrate your business into the Chinese market.
Feasibility Analysis of Strategic Investment
Access China’s feasibility analysis of strategic investment provides the practical guidance for your conducting capital operation in China, including feasibility analysis of merger and acquisition of Chinese enterprises, joint ventures and investment projects, and guides you through any administrative, licensing and certification procedures to achieve a successful entry into the Chinese market.
... fast-paced economic growth has made China the world’s second largest economy and the world’s largest exporter. Its economy has been deeply integrated into the global economy and joined into the existing global order, led its ... Read More
... above 16 % since 1990s. Among them, in-vitro diagnostic reagents represented dynamical growth since 2007. By 2014, total value of in-vitro diagnostic reagents on Chinese healthcare market has reached 4.3 billion US dollars. The in-vitro ... Read More
... world. Along with sustained economic and population growth as well as an ageing population, Chinese healthcare market has maintained annually average growth rate above 16 % since 1990s. Among them, medical devices represented dynamical growth ... Read More
... is first time in history, Chinese pharmaceutical authorities, China Food and Drug Administration officially issued a technical guidance for development and evaluation of biosimilars and defined the pathway of license approval for biosimilars. Chinese pharmaceutical ... Read More
... begun to be implemented on March 1, 2015. The guidance provides an opportunity to reduce risk from the examination uncertainty and approval delays to eat up your time and energy to achieve a successful entry ... Read More
... and approval procedures for innovative medical devices since March 1, 2014, which provides a opportunity to speed up overseas innovative medical devices entry into Chinese market, and reduce risk from the registration examination uncertainty and ... Read More